Handel Anixa Biosciences, Inc. - ANIX CFD
Føj til favorit- Opsummering
- Historisk Data
- Begivenheder
- Resultatopgørelse
- Saldo
- Cash flow
- Ejerskab
Handelsbetingelser
| Spænd | 0.23 | ||||||||
|
Long position, gebyr natten over
Long position overnight fee
Gå til platform | -0.024068% | ||||||||
|
Short position, gebyr natten over
Short position overnight fee
Gå til platform | 0.001846% | ||||||||
| Gebyr natten over, tid | 21:00 (UTC) | ||||||||
| Min. handlet mængde | 1 | ||||||||
| Valuta | USD | ||||||||
| Margen | 20% | ||||||||
| Aktiebørs | United States of America | ||||||||
| Kommission på handel | 0% |
*Information provided by Capital.com
Nøglestatistikker
| Tidligere luk* | 2.97 |
| Åben* | 2.94 |
| 1-Års Ændring* | -1.67% |
| Dagens Spænd* | 2.9 - 3.04 |
| 52-Ugers Spænd | 2.50-6.25 |
| Gennemsnitlig Volumen (10 dage) | 68.87K |
| Gennemsnitlig Volumen (3 måneder) | 1.08M |
| Market Cap | 134.83M |
| P/E-forhold | -100.00K |
| Udestående aktier | 30.92M |
| Omsætning | N/A |
| EPS | -0.40 |
| Dividend (Udbytte %) | N/A |
| Beta | 0.97 |
| Næste indtjeningsopgørelse | N/A |
Al data kommer fra Refinitiv, med undtagelse af data markeret med en asterisk, som er *data fra Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Luk | Change | Change (%) | Åben | High | Low |
|---|---|---|---|---|---|---|
| Jun 29, 2022 | 2.99 | 0.05 | 1.70% | 2.94 | 3.08 | 2.90 |
| Jun 28, 2022 | 2.97 | -0.04 | -1.33% | 3.01 | 3.14 | 2.95 |
| Jun 27, 2022 | 3.16 | 0.15 | 4.98% | 3.01 | 3.19 | 3.01 |
| Jun 24, 2022 | 3.04 | 0.07 | 2.36% | 2.97 | 3.12 | 2.97 |
| Jun 23, 2022 | 3.13 | 0.11 | 3.64% | 3.02 | 3.19 | 3.02 |
| Jun 22, 2022 | 3.18 | 0.21 | 7.07% | 2.97 | 3.18 | 2.97 |
| Jun 21, 2022 | 3.08 | 0.06 | 1.99% | 3.02 | 3.19 | 3.02 |
| Jun 17, 2022 | 3.00 | -0.16 | -5.06% | 3.16 | 3.16 | 2.96 |
| Jun 16, 2022 | 3.10 | 0.15 | 5.08% | 2.95 | 3.18 | 2.90 |
| Jun 15, 2022 | 3.08 | 0.29 | 10.39% | 2.79 | 3.15 | 2.79 |
| Jun 14, 2022 | 2.88 | -0.18 | -5.88% | 3.06 | 3.09 | 2.82 |
| Jun 13, 2022 | 3.07 | -0.18 | -5.54% | 3.25 | 3.31 | 3.04 |
| Jun 10, 2022 | 3.33 | -0.10 | -2.92% | 3.43 | 3.48 | 3.27 |
| Jun 9, 2022 | 3.48 | 0.07 | 2.05% | 3.41 | 3.68 | 3.41 |
| Jun 8, 2022 | 3.50 | 0.23 | 7.03% | 3.27 | 3.54 | 3.27 |
| Jun 7, 2022 | 3.38 | -0.49 | -12.66% | 3.87 | 3.91 | 3.30 |
| Jun 6, 2022 | 3.92 | -0.27 | -6.44% | 4.19 | 4.44 | 3.87 |
| Jun 3, 2022 | 3.94 | 0.16 | 4.23% | 3.78 | 3.96 | 3.61 |
| Jun 2, 2022 | 3.81 | 0.01 | 0.26% | 3.80 | 3.85 | 3.74 |
| Jun 1, 2022 | 3.69 | 0.18 | 5.13% | 3.51 | 3.70 | 3.37 |
Anixa Biosciences, Inc. Events
| Tid (UTC) (UTC) | Land | Begivenhed |
|---|---|---|
| No events scheduled | ||
- Årlig
- Pr kvartal
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Total omsætning | 0 | 0.5125 | 0 | 0.25 | 1.1125 |
| Omsætning | 0 | 0.5125 | 0 | 0.25 | 1.1125 |
| Totale Driftsudgifter | 13.875 | 13.6482 | 9.9782 | 12.14 | 15.4016 |
| Salgs/Generelle/Admin. Udgifter, Total | 7.172 | 7.0735 | 5.597 | 5.66283 | 6.91183 |
| Forskning & Udvikling | 6.703 | 6.18969 | 4.38121 | 5.47343 | 6.81304 |
| Depreciation / Amortization | 0 | 0.41875 | 0.3253 | ||
| Usædvanlig Udgift (Indkomst) | 0 | 0.385 | 0 | 0.585 | 1.35139 |
| Other Operating Expenses, Total | |||||
| Driftsindtægter | -13.875 | -13.1357 | -9.9782 | -11.89 | -14.2891 |
| Renteindkomst (Udgift), Netto Ikke-Drift | 0.104 | 0.00232 | 0.03392 | 0.07135 | 0.04597 |
| Netto Indkomst Før Skat | -13.771 | -13.1279 | -10.0924 | -11.8187 | -14.2431 |
| Netto Indkomst Efter Skat | -13.771 | -13.1279 | -10.0924 | -11.8187 | -14.2431 |
| Netto Indkomst Før Ekstra Ting | -13.595 | -12.9544 | -10.0184 | -11.647 | -13.996 |
| Netto Indkomst | -13.595 | -12.9544 | -10.0184 | -11.647 | -13.996 |
| Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -13.595 | -12.9544 | -10.0184 | -11.647 | -13.996 |
| Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -13.595 | -12.9544 | -10.0184 | -11.647 | -13.996 |
| Fortyndet Netto Indkomst | -13.595 | -12.9544 | -10.0184 | -11.647 | -13.996 |
| Fortyndet Vægtet Gennemsnit Aktier | 30.374 | 28.5789 | 22.229 | 19.7898 | 17.6243 |
| Fortyndet EPS Uden Ekstraordinære Ting | -0.44759 | -0.45329 | -0.45069 | -0.58854 | -0.79413 |
| Dividends per Share - Common Stock Primary Issue | |||||
| Fortyndet Normaliseret EPS | -0.44759 | -0.44 | -0.44403 | -0.55898 | -0.71745 |
| Total Adjustments to Net Income | 0 | ||||
| Minoritetsrente | 0.176 | 0.17352 | 0.07401 | 0.1716 | 0.24706 |
| Gain (Loss) on Sale of Assets | 0 | 0.00545 | -0.14808 |
| Oct 2022 | Jul 2022 | Apr 2022 | Jan 2022 | Oct 2021 | |
|---|---|---|---|---|---|
| Total omsætning | 0 | 0 | 0 | 0 | 0 |
| Omsætning | 0 | 0 | 0 | 0 | 0 |
| Totale Driftsudgifter | 3.609 | 2.797 | 3.589 | 3.88 | 4.07704 |
| Salgs/Generelle/Admin. Udgifter, Total | 1.924 | 1.352 | 1.854 | 2.042 | 1.9038 |
| Forskning & Udvikling | 1.685 | 1.445 | 1.735 | 1.838 | 2.17324 |
| Usædvanlig Udgift (Indkomst) | 0 | 0 | 0 | 0 | 0 |
| Driftsindtægter | -3.609 | -2.797 | -3.589 | -3.88 | -4.07704 |
| Renteindkomst (Udgift), Netto Ikke-Drift | 0.08 | 0.022 | 0.001 | 0.001 | 0.00055 |
| Netto Indkomst Før Skat | -3.529 | -2.775 | -3.588 | -3.879 | -4.07105 |
| Netto Indkomst Efter Skat | -3.529 | -2.775 | -3.588 | -3.879 | -4.07105 |
| Minoritetsrente | 0.053 | 0.029 | 0.044 | 0.05 | 0.05778 |
| Netto Indkomst Før Ekstra Ting | -3.476 | -2.746 | -3.544 | -3.829 | -4.01327 |
| Netto Indkomst | -3.476 | -2.746 | -3.544 | -3.829 | -4.01327 |
| Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -3.476 | -2.746 | -3.544 | -3.829 | -4.01327 |
| Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -3.476 | -2.746 | -3.544 | -3.829 | -4.01327 |
| Fortyndet Netto Indkomst | -3.476 | -2.746 | -3.544 | -3.829 | -4.01327 |
| Fortyndet Vægtet Gennemsnit Aktier | 30.764 | 30.451 | 30.152 | 30.125 | 30.0451 |
| Fortyndet EPS Uden Ekstraordinære Ting | -0.11299 | -0.09018 | -0.11754 | -0.1271 | -0.13357 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | ||
| Fortyndet Normaliseret EPS | -0.11299 | -0.09018 | -0.11754 | -0.1271 | -0.13376 |
| Gain (Loss) on Sale of Assets | 0 | 0.00545 |
- Årlig
- Pr kvartal
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Totale Nuværende Aktiver | 36.0034 | 9.36862 | 6.09312 | 5.53837 | 7.01394 |
| Likvider og Kortsigtede Investeringer | 35.7279 | 9.05706 | 5.84163 | 5.05589 | 6.83937 |
| Likvider & Lignende | 29.1283 | 6.41706 | 3.49163 | 3.05589 | 3.33937 |
| Kortsigtede Investeringer | 6.5996 | 2.64 | 2.35 | 2 | 3.5 |
| Prepaid Expenses | 0.27556 | 0.30933 | 0.18497 | 0.17549 | 0.17457 |
| Total Assets | 36.2574 | 9.45296 | 6.29369 | 6.44854 | 8.81242 |
| Property/Plant/Equipment, Total - Net | 0.25396 | 0.05434 | 0.20057 | 0.07267 | 0.0527 |
| Property/Plant/Equipment, Total - Gross | 0 | 0.29558 | 0.12647 | 0.08843 | |
| Accumulated Depreciation, Total | 0 | -0.09502 | -0.0538 | -0.03573 | |
| Intangibles, Net | 0 | 0.8375 | 1.74578 | ||
| Total Current Liabilities | 1.27053 | 1.18859 | 1.48132 | 1.26511 | 0.88949 |
| Accounts Payable | 0.1362 | 0.23237 | 0.58582 | 0.58201 | 0.48032 |
| Accrued Expenses | 1.13433 | 0.95622 | 0.8955 | 0.6831 | 0.40917 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | |||||
| Total Liabilities | 0.8201 | 0.69161 | 1.05834 | 1.01373 | 0.88949 |
| Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities, Total | 0.22008 | 0 | |||
| Total Equity | 35.4373 | 8.76136 | 5.23535 | 5.43481 | 7.92292 |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | |
| Common Stock | 0.30051 | 0.24249 | 0.20332 | 0.18909 | 0.16603 |
| Additional Paid-In Capital | 239.927 | 200.354 | 186.849 | 175.416 | 163.931 |
| Retained Earnings (Accumulated Deficit) | -204.79 | -191.836 | -181.817 | -170.17 | -156.174 |
| Total Liabilities & Shareholders’ Equity | 36.2574 | 9.45296 | 6.29369 | 6.44854 | 8.81242 |
| Total Common Shares Outstanding | 30.0509 | 24.2487 | 20.3318 | 18.9086 | 16.6028 |
| Total Preferred Shares Outstanding | 0 | 0 | 0 | 0 | 0 |
| Totale Tilgodehavender, Netto | 0.00223 | 0.06653 | 0.30699 | ||
| Accounts Receivable - Trade, Net | 0.00223 | 0.06653 | 0.30699 | ||
| Minority Interest | -0.67051 | -0.49698 | -0.42298 | -0.25138 | |
| Other Long Term Assets, Total | 0 | 0.03 |
| Apr 2022 | Jan 2022 | Oct 2021 | Jul 2021 | Apr 2021 | |
|---|---|---|---|---|---|
| Totale Nuværende Aktiver | 32.563 | 34.994 | 36.0034 | 37.052 | 38.472 |
| Likvider og Kortsigtede Investeringer | 32.231 | 34.53 | 35.7279 | 36.622 | 38.1027 |
| Likvider & Lignende | 27.732 | 29.781 | 29.1283 | 27.2222 | 27.7034 |
| Kortsigtede Investeringer | 4.499 | 4.749 | 6.5996 | 9.39978 | 10.3993 |
| Prepaid Expenses | 0.332 | 0.464 | 0.27556 | 0.43001 | 0.36921 |
| Total Assets | 32.797 | 35.238 | 36.2574 | 37.0624 | 38.4975 |
| Property/Plant/Equipment, Total - Net | 0.234 | 0.244 | 0.25396 | 0.01041 | 0.02557 |
| Other Long Term Assets, Total | 0 | 0 | 0 | ||
| Total Current Liabilities | 1.189 | 1.787 | 1.27053 | 1.20802 | 1.44287 |
| Accounts Payable | 0.093 | 0.504 | 0.1362 | 0.20773 | 0.43801 |
| Accrued Expenses | 1.096 | 1.283 | 1.13433 | 1.00029 | 1.00486 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 0.626 | 1.275 | 0.8201 | 0.5953 | 0.88376 |
| Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | -0.765 | -0.721 | -0.67051 | -0.61273 | -0.55911 |
| Total Equity | 32.171 | 33.963 | 35.4373 | 36.4671 | 37.6138 |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
| Common Stock | 0.302 | 0.301 | 0.30051 | 0.2995 | 0.3145 |
| Additional Paid-In Capital | 244.032 | 242.281 | 239.927 | 236.944 | 233.742 |
| Retained Earnings (Accumulated Deficit) | -212.163 | -208.619 | -204.79 | -200.777 | -196.443 |
| Total Liabilities & Shareholders’ Equity | 32.797 | 35.238 | 36.2574 | 37.0624 | 38.4975 |
| Total Common Shares Outstanding | 30.1547 | 30.1323 | 30.0509 | 29.9499 | 31.4499 |
| Other Liabilities, Total | 0.202 | 0.209 | 0.22008 | ||
| Total Preferred Shares Outstanding | 0 |
- Årlig
- Pr kvartal
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Netto indkomst/Startlinje | -13.1279 | -10.0924 | -11.8187 | -14.2431 | -5.00899 |
| Likvider Fra Driftsaktiviteter | -4.93688 | -6.17567 | -4.74143 | -4.2734 | -3.79671 |
| Likvider Fra Driftsaktiviteter | 0 | 0.03828 | 0.04756 | 0.01844 | 0.04322 |
| Amortization | 0 | 0.41875 | 0.3253 | 0.3253 | |
| Ikke-Likvide Ting | 8.1125 | 4.33743 | 6.1325 | 9.55825 | 0.43553 |
| Ændringer i Driftskapital | 0.07855 | -0.45901 | 0.47842 | 0.0677 | 0.40824 |
| Likvider fra Investeringsaktiviteter | -3.91768 | -0.30579 | -0.52546 | 1.4616 | -2.73519 |
| Kapitaludgifter | 0 | -0.01579 | -0.17546 | -0.0384 | -0.03019 |
| Andre Investerings-Cash-Flow-Ting, Total | -3.91768 | -0.29 | -0.35 | 1.5 | -2.705 |
| Likvider fra Financieringsaktiviteter | 31.5658 | 9.4069 | 5.70262 | 2.52832 | 7.38295 |
| Financiering af Cash-Flow-Ting | 0.01403 | 0 | |||
| Udstedelse (Pensionering) af Aktier, Netto | 31.5658 | 9.4069 | 5.68858 | 2.52832 | 10.3829 |
| Netto Ændring i Likviditet | 22.7112 | 2.92544 | 0.43574 | -0.28348 | 0.85105 |
| Likvid Rente Betalt | 0.00182 | 0.03989 | 0 | 0.27243 | |
| Udstedelse (Pensionering) af Gæld, Netto | 0 | -3 |
| Apr 2022 | Jan 2022 | Oct 2021 | Jul 2021 | Apr 2021 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -7.467 | -3.879 | -13.1279 | -9.05688 | -4.66927 |
| Cash From Operating Activities | -3.503 | -1.197 | -4.93688 | -3.89271 | -2.41195 |
| Cash From Operating Activities | 0 | 0 | 0 | ||
| Non-Cash Items | 4.12 | 2.364 | 8.1125 | 5.26318 | 2.06069 |
| Cash Interest Paid | 2 | 1 | 0.00182 | 0.00168 | 0.0014 |
| Changes in Working Capital | -0.156 | 0.318 | 0.07855 | -0.09901 | 0.19663 |
| Cash From Investing Activities | 2.1 | 1.85 | -3.91768 | -6.72434 | -7.72385 |
| Capital Expenditures | 0 | 0 | 0 | ||
| Other Investing Cash Flow Items, Total | 2.1 | 1.85 | -3.91768 | -6.72434 | -7.72385 |
| Cash From Financing Activities | 0.007 | 0 | 31.5658 | 31.4222 | 31.4222 |
| Financing Cash Flow Items | 0 | -2.54893 | -2.54893 | ||
| Issuance (Retirement) of Stock, Net | 0.007 | 0 | 31.5658 | 33.9711 | 33.9711 |
| Net Change in Cash | -1.396 | 0.653 | 22.7112 | 20.8051 | 21.2864 |
| Investornavn | Investortype | Procent udestående | Aktiebeholdning | Aktieændring | Beholdningsdato | IOmsætningsscore |
|---|---|---|---|---|---|---|
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 4.2268 | 1307142 | 7144 | 2022-12-31 | LOW |
| Titterton (Lewis H Jr) | Individual Investor | 2.5031 | 774070 | 0 | 2023-01-17 | LOW |
| UBS Financial Services, Inc. | Investment Advisor | 2.0131 | 622544 | 853 | 2022-12-31 | LOW |
| Kumar (Amit) | Individual Investor | 1.4943 | 462100 | 0 | 2023-01-17 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.9353 | 289238 | -2985 | 2022-12-31 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.887 | 274289 | 3626 | 2022-12-31 | LOW |
| Long Focus Capital Management LLC | Hedge Fund | 0.5358 | 165701 | 0 | 2022-12-31 | MED |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.3302 | 102100 | 0 | 2022-12-31 | LOW |
| Baskies (Arnold M) | Individual Investor | 0.3234 | 100000 | 0 | 2023-01-17 | LOW |
| Susquehanna International Group, LLP | Investment Advisor | 0.2297 | 71023 | 31115 | 2022-12-31 | MED |
| Raymond James & Associates, Inc. | Research Firm | 0.185 | 57217 | -3629 | 2022-12-31 | LOW |
| Newton Investment Management North America, LLC | Investment Advisor | 0.179 | 55350 | 0 | 2022-12-31 | MED |
| Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.1777 | 54948 | 0 | 2022-12-31 | LOW |
| Morgan Stanley Smith Barney LLC | Investment Advisor | 0.1582 | 48925 | -714 | 2022-12-31 | LOW |
| Renaissance Technologies LLC | Hedge Fund | 0.1549 | 47900 | -9300 | 2022-12-31 | HIGH |
| Citadel Advisors LLC | Hedge Fund | 0.1536 | 47506 | 27896 | 2022-12-31 | HIGH |
| Gottschalk (Emily) | Individual Investor | 0.1477 | 45665 | 0 | 2023-01-17 | LOW |
| BNY Mellon Asset Management | Investment Advisor | 0.1367 | 42268 | -238 | 2022-12-31 | LOW |
| Cambridge Investment Research Advisors, Inc. | Investment Advisor | 0.1297 | 40100 | 25100 | 2022-12-31 | LOW |
| Corecap Advisors Inc | Investment Advisor/Hedge Fund | 0.1171 | 36209 | -1177 | 2022-12-31 | MED |
Hvorfor vælge Capital.com? Vores tal taler for sig selv.
Capital.com Group500K+
Handlende
92K+
Månedlkige, aktive klienter
$53M+
Månedlig investeringsvolumen
$30M+
Hævet hver måned
Handelslommeregner
Udregn dit hypotetiske P&L hvis du havde åbnet en CFD-handel på en given dato (vælg en dato) og lukket den på en anden dato (vælg en dato).
Handelskurtage
0
- 1:1
Gearing
1:1
- 20
- 100
- 500
- 1000
- 10000
Investering
Handelsstørrelse (Gearing x Investering):
Åben
Luk
Short Long
Anixa Biosciences, Inc. Company profile
Om Anixa Biosciences, Inc.
Anixa Biosciences, Inc. er en bioteknologisk virksomhed. Virksomheden udvikler terapier og vacciner med fokus på onkologi og infektionssygdomme. Virksomheden udvikler chimær endokrin receptor T-celle-teknologi, en chimær antigenreceptor T-celle (CAR-T) teknologi med fokus på behandling af kræft i æggestokkene og antivirale lægemiddelkandidater til behandling af COVID-19 med fokus på at hæmme visse virale proteinfunktioner i virusset. Virksomheden er også ved at udvikle en vaccine mod triple negativ brystkræft (TNBC), den dødelige form for brystkræft, og en vaccine mod kræft i æggestokkene. Dens CAR-T-teknologi kan anvendes som behandling mod flere forskellige typer solide tumorer. Selskabets segmenter omfatter CAR-T-terapier, kræftvacciner, antivirale terapier, aktiviteter inden for kræftdiagnostik og patentlicensaktiviteter. Dets datterselskab Certainty Therapeutics, Inc. (Certainty) udvikler lægemidler til immunoterapi mod kræft.
| Industry: | Biotechnology & Medical Research (NEC) |
3150 Almaden Expy Ste 250
SAN JOSE
CALIFORNIA 95118
US
Resultatopgørelse
- Annual
- Quarterly
Folk ser også
Leder du stadig efter en mægler, du kan stole på?
Deltag sammen med 500.000+ handlende over hele verden, der valgte at handle hos Capital.com